IPTAKALIM ATTENUATES SELF-ADMINISTRATION AND ACQUIRED GOAL-TRACKING BEHAVIOR CONTROLLED BY NICOTINE

Iptakalim is an ATP-sensitive potassium channel opener, as well as an α(4)β(2)-containing nicotinic acetylcholine receptor (nAChR) antagonist. Pretreatment with iptakalim diminishes nicotine-induced dopamine (DA) and glutamate release in the nucleus accumbens. This neuropharmacological profile sugge...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Charntikov, S., Swalve, N., Pittenger, S., Fink, K., Schepers, S., Hadlock, G. C., Fleckenstein, A. E., Hu, G., Li, M., Bevins, R. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3864985/
https://ncbi.nlm.nih.gov/pubmed/23916479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2013.07.019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak